Skip to content

King Pharmaceuticals KG Program Services — Net loan receivable from related party

Other segment segments

Legacy Reinsurance
$78.61M

Similar metrics at other companies

ESQ
ESQRelated Party Loans Receivable
$0
Duos Technologies Group, Inc. logo
DUOTAccounts Receivable Net Related Parties
$688.21K-60.9%
Trustco Bank Corp logo
TRSTLoans And Leases Receivable Related Parties Period Increase Decrease
$1.13M
SUI
SUIGLoans And Leases Receivable Related Parties
$0
Bank of Marin Bancorp logo
BMRCLoans And Leases Receivable Related Parties Proceeds
$22.75K-97.1%
Bank7 Corp. logo
BSVNLoans And Leases Receivable Related Parties Proceeds
$134K-42.9%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LoansAndLeasesReceivableRelatedParties.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's program services — net loan receivable from related party.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's program services — net loan receivable from related party?
King Pharmaceuticals (KG) reported program services — net loan receivable from related party of $0 in Q1 2026.
What does program services — net loan receivable from related party mean?
This represents the outstanding balance of loans provided to affiliated entities within the Program Services segment, net of any applicable valuation allowances. It reflects the extent of intercompany financing and capital support provided to related parties. Monitoring this balance is essential for assessing credit risk exposure and the liquidity position of the segment.